Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 514a-3 (miR-514a-3p) is a small, non-coding RNA molecule that acts by post-transcriptionally regulating gene expression, primarily by binding to target mRNAs leading to their translational repression or degradation[2]. It is a member of an X-linked miRNA cluster with multiple genomic loci and is expressed in primates (including humans) but not in rodents[1][2]. miR-514a-3 is particularly implicated in the regulation of neuronal development: it promotes dendritic growth, increases neuronal soma size, and upregulates mTOR signaling[1]. It is also suggested to be involved in evolutionary features of primate brains and is aberrantly expressed in certain neurological disorders[1][2]. Direct disease associations or therapeutic targeting approaches remain under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 514a-3 (miR-514a-3p).